These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17962055)

  • 1. A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control: advantages of pathway-based discovery.
    Hellerstein MK
    Metab Eng; 2008 Jan; 10(1):1-9. PubMed ID: 17962055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting complexity and the robustness of network architecture for drug discovery.
    Hellerstein MK
    J Pharmacol Exp Ther; 2008 Apr; 325(1):1-9. PubMed ID: 18202293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What does systems biology mean for drug development?
    Schrattenholz A; Soskić V
    Curr Med Chem; 2008; 15(15):1520-8. PubMed ID: 18537627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel chemical genetic approaches to the discovery of signal transduction inhibitors.
    Shokat K; Velleca M
    Drug Discov Today; 2002 Aug; 7(16):872-9. PubMed ID: 12546954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(6):1337-1358. PubMed ID: 28039691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases.
    Cho CH; Nuttall ME
    Expert Opin Ther Targets; 2002 Dec; 6(6):679-89. PubMed ID: 12472380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging human genetics to guide drug target discovery.
    Stitziel NO; Kathiresan S
    Trends Cardiovasc Med; 2017 Jul; 27(5):352-359. PubMed ID: 27686272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A paradigm shift in medicine: A comprehensive review of network-based approaches.
    Conte F; Fiscon G; Licursi V; Bizzarri D; D'Antò T; Farina L; Paci P
    Biochim Biophys Acta Gene Regul Mech; 2020 Jun; 1863(6):194416. PubMed ID: 31382052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Main approaches to target discovery and validation.
    Sioud M
    Methods Mol Biol; 2007; 360():1-12. PubMed ID: 17172722
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.